REGENXBIO Securities Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
REGENXBIO · REGENXBIO securities · New Filing
Last updated
Case overview
- Defendant company
- REGENXBIO
- Product or service
- REGENXBIO securities
- Case status
- New Filing
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Participation information
Availability is based on each listed participation option and its deadline.
Pomerantz LLP Investor Inquiry
Investors with losses on their investment in REGENXBIO are advised to contact Pomerantz LLP.
Contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, or toll-free at 888-4-POMLAW, Ext. 7980. Email inquiries are encouraged to include a mailing address, telephone number, and number of shares purchased.
- Type
- Law Firm Signup
- Status
- Unknown
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- REGENXBIO Securities Class Action
Eagle-Tribune ·